GlassScriptPhysician profile
Andrea Bernard
NPI 1427582956
$1,575.09
in general payments reported to CMS, 2019-2025
21 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $419 · 2022: $150 · 2023: $177 · 2024: $393 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $458.55 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $300.65 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $131.13 | 2021-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $109.91 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.85 | 2021-2025 | Lifevest |
| Cvrx, INC. | $79.18 | 2021-2025 | Barostim Neo System |
| Boston Scientific Corporation | $57.82 | 2021-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.90 | 2025 | Jardiance |
| Pfizer INC. | $35.16 | 2025 | |
| Vital Connect, INC | $29.16 | 2024 | Vitalpatch Rtm |
| Abiomed | $29.02 | 2025 | |
| Exact Sciences Corporation | $27.43 | 2024 | Cologuard Collection Kit |
| Heartflow, INC. | $24.46 | 2023 | Ffrct |
| Inspire Medical Systems, INC. | $24.04 | 2025 | Inspire |
| Lantheus Medical Imaging, INC. | $21.87 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $20.78 | 2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $19.89 | 2025 | Opsynvi, Uptravi |
| Scpharmaceuticals INC. | $18.57 | 2025 | |
| Merck Sharp & Dohme LLC | $17.09 | 2025 | Winrevair |
| E.R. Squibb & Sons, L.L.C. | $17.00 | 2025 | Camzyos |
| Nevro Corp. | $13.63 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Bernard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.